Final program

The way ahead: working agenda for the next months
Panel discussion on:

1. establishment of working groups for methods requiring improvement and standardization
2. sharing of standards, control material
3. sharing of best practice
4. dissemination activities

Session 1
Methods requiring improvement
and standardization

1. Measurement of functional activity of CP, AP and LP
   Facilitators: Zoltán Prohászka and Bo Nilsson
2. C1 inhibitor function and autoantibodies
   Facilitators: Marco Cicardi and Lilian Varga
3. Factor H,  Factor I, C3Nef, Anti-factor H
   Facilitators: Veronique Fremeaux-Bacchi, Richard Smith or Yuzhou Zhang
4. C1q, C3, C4 and  Anti-C1q
   Facilitators: Paul Morgan and Michael Kirschfink
5. SC5b-9 and other activation products (e.g. C3a, C3d)
   Facilitators: Ashley Frazer-Abel and Margarita Lopez Trascasa

Session 2
Organization of the next EQA

List of parameters to be included in EQA6
Extension to molecular genetic analysis

Preparation/collection of pathological control
samples, patient/problem based interpretative
reporting

Organizational platform (INSTAND)

• Registration mode and fees
• Data collection
• Data evaluation
• Report and Certificates

Session 3
Dissemination activities

Discussion on preparation, publication and dissemination of guidelines for diagnostic complement analysis

Discussion on the publication of the list of professional diagnostic laboratories for complement on the ECN/ICS/IUIS websites